It has also been reported that miR-33a can inhibit the proliferation of non-small cell lung cancer (NSCLC) cells by targeting M6A regulatory factor METTL3 mRNA 3'UTR binding site [11]. Here, METTL3 is linked to non-small cell lung carcinoma.